XELJANZ

Prolonged-release tablet, 11mg
RxActive license

Active substance (INN)

tofacitinib

Pharmaceutical form

Pharmaceutical formProlonged-release tablet
Strength11mg
PackagingUkupno 28 tableta sa produženim oslobađanjem u blisteru (4x7) u kartonskoj kutiji
ManufacturerPfizer Manufacturing Deutschland GmbH, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L04AF01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJune 8, 2023

Analogs in Montenegro

2

Other medicines with the same active substance

XELJANZRx
Film-coated tablet, 10mgPfizer Manufacturing Deutschland GmbH
XELJANZRx
Film-coated tablet, 5mgPfizer Manufacturing Deutschland GmbH
Source: CInMED register